No Data
No Data
Buy Rating on Kiora Pharmaceuticals: Strong Financials and Promising KIO-301 Progress
Kiora Pharmaceuticals Shares Rise After Q2 Loss Narrows
Kiora Pharmaceuticals GAAP EPS of -$0.53 Beats by $0.33
Kiora Pharmaceuticals 2Q Loss/Shr 53c >KPRX
Kiora Pharmaceuticals 2Q Loss $2.2M >KPRX
Earnings Flash (KPRX) KIORA PHARMACEUTICALS Reports Q2 Revenue $20,000
No Data